191 related articles for article (PubMed ID: 24006872)
1. Identification of upstream regulators for prognostic expression signature genes in colorectal cancer.
Bae T; Rho K; Choi JW; Horimoto K; Kim W; Kim S
BMC Syst Biol; 2013 Sep; 7():86. PubMed ID: 24006872
[TBL] [Abstract][Full Text] [Related]
2. Identification of upstream regulators for synovial expression signature genes in osteoarthritis.
Fei Q; Lin J; Meng H; Wang B; Yang Y; Wang Q; Su N; Li J; Li D
Joint Bone Spine; 2016 Oct; 83(5):545-51. PubMed ID: 26832188
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
4. Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia.
Yepes S; Torres MM; López-Kleine L
BMC Genomics; 2015 Nov; 16():1002. PubMed ID: 26606983
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer.
Jiang M; Cheng Y; Wang D; Lu Y; Gu S; Wang C; Huang Y; Li Y
EBioMedicine; 2021 Jan; 63():103150. PubMed ID: 33279858
[TBL] [Abstract][Full Text] [Related]
6. ToP: a trend-of-disease-progression procedure works well for identifying cancer genes from multi-state cohort gene expression data for human colorectal cancer.
Chung FH; Lee HH; Lee HC
PLoS One; 2013; 8(6):e65683. PubMed ID: 23799036
[TBL] [Abstract][Full Text] [Related]
7. An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers.
Eskandari E; Mahjoubi F; Motalebzadeh J
Gene; 2018 Dec; 679():150-159. PubMed ID: 30193961
[TBL] [Abstract][Full Text] [Related]
8. Trimming of mammalian transcriptional networks using network component analysis.
Tran LM; Hyduke DR; Liao JC
BMC Bioinformatics; 2010 Oct; 11():511. PubMed ID: 20942926
[TBL] [Abstract][Full Text] [Related]
9. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
Yang L; Feng S; Yang Y
Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
[TBL] [Abstract][Full Text] [Related]
10. A computational procedure for identifying master regulator candidates: a case study on diabetes progression in Goto-Kakizaki rats.
Piao G; Saito S; Sun Y; Liu ZP; Wang Y; Han X; Wu J; Zhou H; Chen L; Horimoto K
BMC Syst Biol; 2012; 6 Suppl 1(Suppl 1):S2. PubMed ID: 23046543
[TBL] [Abstract][Full Text] [Related]
11. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
12. Gene dysregulation analysis builds a mechanistic signature for prognosis and therapeutic benefit in colorectal cancer.
Li Q; Dai W; Liu J; Sang Q; Li YX; Li YY
J Mol Cell Biol; 2020 Jul; 12(11):881-893. PubMed ID: 32717065
[TBL] [Abstract][Full Text] [Related]
13. Development of a multi-gene-based immune prognostic signature in ovarian Cancer.
Cao T; Shen H
J Ovarian Res; 2021 Jan; 14(1):20. PubMed ID: 33509250
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
15. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
[TBL] [Abstract][Full Text] [Related]
16. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
Recamonde-Mendoza M; Werhli AV; Biolo A
Gene; 2019 May; 698():157-169. PubMed ID: 30844478
[TBL] [Abstract][Full Text] [Related]
17. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
Shi M; Beauchamp RD; Zhang B
PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
[TBL] [Abstract][Full Text] [Related]
18. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
19. Master regulators used as breast cancer metastasis classifier.
Lim WK; Lyashenko E; Califano A
Pac Symp Biocomput; 2009; ():504-15. PubMed ID: 19209726
[TBL] [Abstract][Full Text] [Related]
20. Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer.
Wang H; Luo J; Liu C; Niu H; Wang J; Liu Q; Zhao Z; Xu H; Ding Y; Sun J; Zhang Q
BMC Bioinformatics; 2017 Sep; 18(1):388. PubMed ID: 28865443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
